Article Details
Retrieved on: 2024-05-20 19:52:19
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article examines safety concerns related to Covaxin, a COVID vaccine developed by Bharat Biotech, as highlighted by a BHU study. ICMR criticized the study's design and dissociated itself from it, despite Bharat Biotech defending Covaxin's safety. The tags help contextualize the topic within India's pandemic response and vaccination efforts.
Article found on: www.businesstoday.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here